Abstract: The order processing system S receives the designation of the number of ordering users related to the group order, receives the selection of items related to the order, sorts the selected items for each of as many users as the designated number of the users, and performs settlement for the sorted items.

Abstract: The order processing system S receives the designation of the number of ordering users related to the group order, receives the selection of items related to the order, and sorts and displays the selected items for each of as many users as the designated number of ordering users.

Abstract: Provided is a rubber composition containing non-fibrous titanate compound particles and having excellent dispersibility of the titanate compound particles and excellent wet grip performance and wear resistance. A rubber composition containing a rubber component mixed with: non-fibrous titanate compound particles having an average particle diameter of less than 30 ?m and a BET specific surface area of 2 m2/g or more; and silica particles having a BET specific surface area of 50 to 250 m2/g.

Abstract: Provided is a rubber composition containing non-fibrous titanate compound particles and having excellent dispersibility of the titanate compound particles and excellent wet grip performance and wear resistance. A rubber composition containing a rubber component mixed with: non-fibrous titanate compound particles having an average particle diameter of less than 30 ?m and a BET specific surface area of 2 m2/g or more; and silica particles having a BET specific surface area of 50 to 250 m2/g.

Abstract: The present invention relates to novel aminoglycoside antibiotics, a process for producing the same, and pharmaceutical use thereof. More specifically, the present invention relates to compounds represented by formula (I), a process for producing the same, and use of the same as antimicrobial agents. wherein R represents amino or hydroxyl.

Abstract: The present invention relates to novel aminoglycoside antibiotics, a process for producing the same, and pharmaceutical use thereof. More specifically, the present invention relates to compounds represented by formula (I), a process for producing the same, and use of the same as antimicrobial agents. wherein R represents amino or hydroxyl.

Abstract: The present invention provides a composition for use as a harmful organism control agent comprising as an active ingredient one or more of compounds represented by formula (I) or salts thereof and an agriculturally or zootechnically acceptable carrier. wherein Het represents pyridyl; X represents an oxygen atom; R1, R2, R3, R7, R10a, R10b, R11, and R12 represent a hydrogen atom; R4, R5, and R6 represent a hydrogen atom, hydroxyl, optionally substituted C1-18 alkylcarbonyloxy, optionally substituted C1-18 alkylsulfonyloxy, optionally substituted arylcarbonyloxy, C1-6 alkyloxy-C1-6 alkyloxy, C1-6 alkyloxy-C1-6 alkyloxy-C1-6 alkyloxy; R8 represents a hydrogen atom; and R13a, R13b, and R13c represent methyl.

Abstract: To efficiently and easily manufacture carbon nanotubes oriented in one direction. A method for manufacturing carbon nanotubes is characterized by including the steps of: bringing crystalline metal oxide particles into contact with a solution containing metal ions serving as a catalyst for forming carbon nanotubes, thereby attaching the catalyst to the surfaces of the metal oxide particles; subjecting the surfaces of the metal oxide particles to which the catalyst is attached to a CVD method or a combustion method, thereby forming carbon nanotubes on the surface of each of the metal oxide particles and resulting in producing metal oxide particles each supporting carbon nanotubes grown substantially perpendicularly to the surface of the metal oxide particle and in parallel with each other; and removing metal oxide particles from the metal oxide particles supporting carbon nanotubes.

Abstract: The present invention relates to novel aminoglycoside antibiotics, a process for producing the same, and pharmaceutical use thereof. More specifically, the present invention relates to compounds represented by formula (I), a process for producing the same, and use of the same as antimicrobial agents. wherein R represents amino or hydroxyl.

Abstract: The invention provides novel metal oxide particles on which carbon nanotubes are supported. Needle- or flake-like crystalline metal oxide particles characterized in that carbon nanotubes grown parallel to each other in the direction nearly perpendicular to the surface of each particle are supported on the surfaces of the particles and that the carbon nanotubes supported on the particles are 1 to 500 ?m in length in the direction nearly perpendicular to the surface of each particle.

Abstract: The present invention provides a combustion-based method and apparatus for producing and isolating carbon nanotubes. The nanotubes are formed when hot combustion gases are contacted with a catalytic surface, which is readily separated from the catalyst support and subsequently dissolved. The process is suitable for large-scale manufacture of carbon nanotubes.

Abstract: Carbon nanotubes are more efficiently produced with a simpler apparatus. The process, which is for producing carbon nanotubes by the combustion method, is characterized by comprising: a step in which a catalyst-supporting powder comprising a base powder and a catalyst supported on the surface thereof is prepared; a step in which the catalyst-supporting powder is deposited on a porous support (2) having through-holes through which a flame passes, so that the powder particles are held in the through-holes without tenaciously adhering to one another; a step in which the porous support (2) having the catalyst-supporting powder held thereon is disposed in a combustion oven (1) in which one end (1b) is open; and a step in which a carbon-containing flame is generated in a burner part (3) disposed at the other end (1a) of the combustion oven (1) and the flame is fed to the through-holes of the porous support (2) to produce carbon nanotubes on the surface of the catalyst-supporting powder present in the through-holes.

Abstract: Disclosed is a carbon nanotube-loaded inorganic particle which exhibits excellent reinforcing performance when blended in resins or the like. Specifically disclosed is a carbon nanotube-loaded inorganic particle characterized in that the surface of an inorganic particle is loaded with carbon nanotubes. This carbon nanotube-loaded inorganic particle can be produced by loading the surface of a fiber-like or plate-like inorganic particle of potassium titanate or wollastonite with fine particles of an iron catalyst and growing carbon nanotubes on the surface of the inorganic particle by a polystyrene method or the like.

Abstract: An objective of the present invention is to provide a method of producing soyasapogenol B and to provide novel microorganisms. The present invention provides a method of producing soyasapogenol B comprising the steps of culturing microorganisms that belong to genus Neocosmospora or genus Eupenicillium, in a medium containing a glycoside having soyasapogenol B as an aglycone, and then collecting soyasapogenol B from the resulting culture.

Abstract: The present invention provides a polycrystalline hexagonal boron nitride compound comprising fine crystals of the order of nanometers. The present invention also provides a hexagonal boron nitride characterized in that the boron nitride is 20 to 200 nm in mean particle size and comprises at least 80 wt. % of particles having sizes in the range of the mean particle size±30%. The present invention further provides a fine hexagonal boron nitride powder characterized in that the powder comprises particles in the form of circular disks or elliptical disks having a minor axis La, a major axis Lb and a thickness t which satisfy the following expressions. 50 nm≦La≦Lb≦400 nm 20 nm≦t≦150 nm t≦La 0.5≦La/Lb≦1.0.

Abstract: As novel compounds which possess a chymase-inhibiting activity and are useful as medicines for a variety of applications, there are provided SF2809-I substance, SF2809-II substance, SF2809-III substance, SF2809-IV substance, SF2809-V substance and SF2809-VI substance which are represented by the following general formula (VII) wherein R1 is a hydrogen atom, phenyl group or p-hydroxyphenyl group, and R2 is acetylamino group —NHCOCH3 or hydroxyl group, or pharmaceutically acceptable salts thereof, and which possess the chymase-inhibiting activity. Also provided is a process for the preparation of the above SF2809 substances, as well as a pharmaceutical composition comprising one of those substances.

Abstract: The present invention attains a microwave absorber attachment in a readily, rapidly and stable manner. According to the microwave absorber attaching method and structure of the present invention, a plurality of ferrite plates 4 are bonded to a shield plate 2 at an installation place such as the ceiling, a wall, the floor or the like; the base portion of a support rod 6 is connected to the ferrite plates 4, causing the support rod 6 to project therefrom; a microwave absorber 1 is placed with its base portion placed along the ferrite plates 4; the support rod 6 passes through a tip opening 11 of the microwave absorber 1, causing the support rod 6 to project therethrough; a covering tray 8 allows for the support rod 6 to pass therethrough to cover the microwave absorber 1; and a fastening member is fastened to a tip threaded portion 12 of the support rod 6, thus attaching the microwave absorber 1 to the installation place. The gaps between adjacent ferrite plates 4 are filled with a magnetic sealing agent.

Abstract: The present invention provides a polycrystalline hexagonal boron nitride compound comprising fine crystals of the order of nanometers.

Abstract: The present invention provides a polycrystalline hexagonal boron nitride compound comprising fine crystals of the order of nanometers. The present invention also provides a hexagonal boron nitride characterized in that the boron nitride is 20 to 200 nm in mean particle size and comprises at least 80 wt. % of particles having sizes in the range of the mean particle size ±30%. The present invention further provides a fine hexagonal boron nitride powder characterized in that the powder comprises particles in the form of circular disks or elliptical disks having a minor axis La, a major axis Lb and a thickness t which satisfy the following expressions 50 nm≦La≦Lb≦400 nm 20 nm≦t≦150 nm t≦La 0.5≦La/Lb≦1.0.

Abstract: A liquid crystal display cell comprising a pair of flexible polymer film substrates having a transparent electrode disposed on the surface thereof and a liquid crystal material sandwiched therebetween. The transparent electrode is a metal oxide film which has a surface resistivity of not greater than 100 ohm per square, a bending property of not greater than 2.0, a curling degree, H, of 0<H<5 mm and a transmittance to light of 550 nm of not less than 75%. Further, this metal oxide is substantially amorphous, and is formed by a DC sputtering method.